Search Results

First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma

Mantle cell is an aggressive form of lymphoma Rye Brook, N.Y., January , – Acalabrutinib (Calquence®) is the first ever drug of its type approved f…

News Release

FDA’s Recent Approval of 2 CAR T-Cell Therapies a ‘Big Step Toward’ Long-Term Control of Myeloma for More Patients

The FDA has approved (Carvykti™) and (Abecma®) for earlier treatment of multiple myeloma.Rye Brook, N.Y., April , – The U.S. Food and Drug Administ…

News Release

FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma

Rye Brook, N.Y., March , – Today’s vote by the FDA’s Oncologic Drugs Advisory Committe (ODAC), a group of independent cancer experts, stating that th…

News Release

FDA Expands Use of Leukemia Treatment to Include Children

LLS supported the very first conjugate gemtuzumab ozogamicin, which targets CD33, and was approved in to treat acute myeloid leukemia.

News Release

FDA Approves Treatment for Myelofibrosis and Anemia

Rye Brook, N.Y., September , – The U.S. Food and Drug Administration (FDA) recently approved momelotinib (Ojjaara™) for use in adults with intermedia…

News Release

FDA Approves Targeted Therapy for Patients with Newly Diagnosed Multiple Myeloma

LLS was an early funder of research that identified the CD38 protein as a target for blood cancer treatment Rye Brook, N.Y., October ,  – The U.S. Fo…

News Release

FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma

Epcoritamab works by engaging the immune system to kill cancer cells Rye Brook, N.Y., June ,  – The U.S. Food and Drug Administration (FDA) on Wednesd…

News Release

FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia

Asciminib provides another option to help CML patients live longer, healthier lives Rye Brook, N.Y., December , – The U.S. Food and Drug Administrati…

News Release

FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma

The FDA continues to expand availability of breakthrough CAR immunotherapy to benefit more blood cancer patientsRye Brook, N.Y., May , – The U.S. Fo…

News Release

Ella

Meet Ella. Lymphoma survivor. cheerleader. Ella's first symptoms, at age /, had all the indications of child abuse, until doctors discovered a large…

FDA Approves New Targeted Treatment for Acute Myeloid Leukemia

Rye Brook, N.Y., July , – The U.S. Food and Drug Administration (FDA) last week approved quizartinib (Vanflyta®) in combination with standard chemoth…

News Release

The Follicular Lymphoma Foundation Joins Forces With The Leukemia & Lymphoma Society to Bring Hope to Those Living With Follicular Lymphoma

AUGUST , - The Follicular Lymphoma Foundation (FLF) and The Leukemia & Lymphoma Society (LLS) have joined forces in an unprecedented strategic partne…

Research: Grants

The Leukemia & Lymphoma Society and Blood Cancer UK Team Up to Award $4.25M for Research into Ways to Prevent Leukemia

RYE BROOK, N.Y., February , — The Leukemia & Lymphoma Society (LLS) and Blood Cancer UK announced today a , $. million grant to launch a research pro…

News Release

The Leukemia & Lymphoma Society Honors 6 Scientists for their Contributions to Blood Cancer Research at Event During American Society of Hematology Annual Meeting

San Diego, December , – Using the latest genetic tools, Elvin Wagenblast, Ph.D., is dissecting blood cells to explain exactly why and how some go fr…

News Release

Shred For Red: Communities Nationwide to Join Olympians at Deer Valley Resort to Support Blood Cancer Patients

(RYE BROOK, N.Y., November , ) - The Leukemia & Lymphoma Society (LLS) is kicking off the ski season by gathering communities nationwide at LLS’s "Shr…

News Release

Skies Across North America to Light Up This Fall in Support of Blood Cancer Patients

The Leukemia & Lymphoma Society kicks off philanthropic campaign Light The Night; communities nationwide encouraged to learn why awareness and support…

News Release

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

RYE BROOK, N.Y., December , – The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of five scientific invest…

News Release

The Leukemia & Lymphoma Society (LLS) Invests Nearly $6.5 Million in Research Investigating the Causes of Inequitable Access to Blood Cancer Treatment and Care

LLS’s Equity in Access Research Program Awards Four New Grants to Researchers Studying the Relationship Between Health Insurance and Access to Care an…

News Release